Embecta Corp.
NasdaqGS:EMBC Voorraadrapport
Marktkapitalisatie: US$898.4m
Embecta Toekomstige groei
Future criteriumcontroles 3/6 De verwachting is dat Embecta de winst en omzet met respectievelijk 29% en 1.3% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 27% per jaar.
Belangrijke informatie
27.0%
Groei van de winst per aandeel
Medical Equipment winstgroei 17.3% Inkomstengroei 1.3% Toekomstig rendement op eigen vermogen n/a Dekking van analisten Good
Laatst bijgewerkt 19 Sep 2024
Recente toekomstige groei-updates
Toon alle updates
Embecta Corp. to Report Q4, 2024 Results on Nov 26, 2024 Nov 13
At US$16.33, Is It Time To Put Embecta Corp. (NASDAQ:EMBC) On Your Watch List? Nov 07
It's A Story Of Risk Vs Reward With Embecta Corp. (NASDAQ:EMBC) Sep 24
Embecta Corp. Receives 510(k) Clearance from the U.S. Food and Drug Administration for Disposable Insulin Delivery System Sep 03
Investor sentiment improves as stock rises 24% Aug 29
Embecta (NASDAQ:EMBC) Will Pay A Dividend Of $0.15 Aug 16
Third quarter dividend of US$0.15 announced Aug 14
Embecta Corp. Just Beat EPS By 79%: Here's What Analysts Think Will Happen Next Aug 14
Price target increased by 7.1% to US$16.07 Aug 11 Embecta Corp. Revises Earnings Guidance for the Fiscal Year 2024
Investor sentiment improves as stock rises 18% Jul 22
Embecta Corp. to Report Q3, 2024 Results on Aug 09, 2024 Jul 19
When Should You Buy Embecta Corp. (NASDAQ:EMBC)? Jul 13
Consensus EPS estimates increase by 38% May 16
Earnings Beat: Embecta Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models May 12
Price target decreased by 9.1% to US$15.00 May 12
Second quarter dividend of US$0.15 announced May 12
New major risk - Revenue and earnings growth May 10 Embecta Corp. Provides Earnings Guidance for the Fiscal Year 2024
Second quarter 2024 earnings released: EPS: US$0.50 (vs US$0.24 in 2Q 2023) May 09
Investor sentiment improves as stock rises 38% May 09
Embecta Corp. to Report Q2, 2024 Results on May 09, 2024 Apr 24
Investor sentiment deteriorates as stock falls 20% Apr 12
Embecta's (NASDAQ:EMBC) Dividend Will Be $0.15 Feb 21
Upcoming dividend of US$0.15 per share Feb 20
First quarter dividend of US$0.15 announced Feb 12
First quarter 2024 earnings: EPS and revenues exceed analyst expectations Feb 11
New major risk - Revenue and earnings growth Feb 10 Embecta Corp. Updates Earnings Guidance for the Fiscal Year 2024
Embecta Corp. to Report Q1, 2024 Results on Feb 09, 2024 Jan 25
Embecta Corp. Announces Food and Drug Administration 510(K) Submission for Insulin Patch Pump Jan 10
Embecta Corp. Announces Food and Drug Administration 510(K) Submission for Insulin Patch Pump Jan 09
Embecta Corp., Annual General Meeting, Feb 07, 2024 Dec 20
Full year 2023 earnings: EPS misses analyst expectations Nov 24 Embecta Corp. to Report Q4, 2023 Results on Nov 21, 2023
Price target decreased by 27% to US$16.00 Oct 18
Investor sentiment deteriorates as stock falls 15% Oct 03
Investor sentiment deteriorates as stock falls 17% Aug 21
Upcoming dividend of US$0.15 per share at 3.2% yield Aug 17
Consensus EPS estimates fall by 12% Aug 15 Embecta Corp. Revises Earnings Guidance for the Fiscal Year 2023
Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Aug 08
Price target decreased by 21% to US$22.00 Jul 18
Embecta Corp.'s (NASDAQ:EMBC) Prospects Need A Boost To Lift Shares Jul 16
Embecta Corp. Announces Resignation of Ajay Kumar as Chief Human Resources Officer, Effective July 16, 2023 Jul 06
Consensus EPS estimates increase by 13% May 19
Upcoming dividend of US$0.15 per share at 2.1% yield May 18 Embecta Corp. Revises Revenue Guidance for the Fiscal Year 2023
Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind May 13
Embecta Corp. (NASDAQ:EMBC) Shares Could Be 37% Below Their Intrinsic Value Estimate Mar 30
Consensus EPS estimates increase by 15% Feb 21
Independent Non-Executive Chairman recently bought US$102k worth of stock Feb 20
Embecta Corp. Just Recorded A 22% EPS Beat: Here's What Analysts Are Forecasting Next Feb 17
Upcoming dividend of US$0.15 per share at 1.9% yield Feb 17
Independent Non-Executive Chairman recently bought US$101k worth of stock Feb 16 Embecta Corp. Declares Quarterly Cash Dividend, Payable on March 13, 2023
First quarter 2023 earnings: EPS and revenues exceed analyst expectations Feb 14
Investor sentiment improves as stock rises 15% Jan 26
Embecta Corp. to Report Q1, 2023 Results on Feb 14, 2023 Jan 25
Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Dec 23
Consensus EPS estimates fall by 44% Dec 21 Embecta Corp. Provides Revenue Guidance for the Fiscal Year 2023
Investor sentiment deteriorated over the past week Dec 20
High number of new and inexperienced directors Nov 16
Investor sentiment improved over the past week Nov 12
High number of new and inexperienced directors Oct 28
Embecta Corp., Annual General Meeting, Feb 09, 2023 Oct 01
Embecta Corp.(NasdaqGS:EMBC) dropped from FTSE All-World Index (USD) Sep 19
Embecta: Comments On 2nd Earnings Since Spin Off Sep 04
Some Investors May Be Willing To Look Past Embecta's (NASDAQ:EMBC) Soft Earnings Aug 23
Third quarter 2022 earnings: Revenues exceed analyst expectations Aug 16 Embecta Corp. Revises Revenue Guidance for the Second-Half Fiscal Year 2022
Embecta GAAP EPS of $1.07 beats by $0.20, revenue of $291.1M beats by $14.24M Aug 15
Embecta Corp. to Report Q3, 2022 Results on Aug 15, 2022 Jul 06
Embecta Is A Winner In A Growing Market Jun 07
Second quarter 2022 earnings released May 15
Embecta Corp. Provides Revenue Guidance for the Last Six Months of Fiscal Year 2022 May 14
Embecta Corp. to Report Q2, 2022 Results on May 13, 2022 Apr 20
Investor sentiment deteriorated over the past week Apr 07 Embecta Corp.(NasdaqGS:EMBC) dropped from S&P 500 Ex-Financials, Real Estate, Utilities and Transportation Index
Winst- en omzetgroeiprognoses NasdaqGS:EMBC - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions ) Datum Inkomsten Inkomsten Vrije kasstroom Geldmiddelen uit operationele activiteiten Gem. Aantal analisten 9/30/2027 1,167 N/A 113 N/A 1 9/30/2026 1,134 119 132 200 4 9/30/2025 1,120 102 127 195 6 9/30/2024 1,114 58 1 28 6 6/30/2024 1,119 70 14 39 N/A 3/31/2024 1,133 70 9 32 N/A 12/31/2023 1,122 55 -30 -6 N/A 9/30/2023 1,121 70 41 68 N/A 6/30/2023 1,114 47 70 96 N/A 3/31/2023 1,119 94 114 138 N/A 12/31/2022 1,116 160 309 334 N/A 9/30/2022 1,130 224 388 412 N/A 6/30/2022 1,156 338 411 440 N/A 3/31/2022 1,160 380 506 537 N/A 12/31/2021 1,169 408 442 474 N/A 9/30/2021 1,165 415 417 456 N/A 9/30/2020 1,086 428 457 499 N/A 9/30/2019 1,109 432 436 505 N/A
Meer tonen
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei EMBC ( 29% per jaar) ligt boven de spaarquote ( 2.6% ).
Winst versus markt: De winst van EMBC ( 29% per jaar) zal naar verwachting sneller groeien dan de US markt ( 15.5% per jaar).
Hoge groeiwinsten: De winst van EMBC zal naar verwachting de komende 3 jaar aanzienlijk groeien.
Omzet versus markt: De omzet van EMBC ( 1.3% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 8.9% per jaar).
Hoge groei-inkomsten: De omzet van EMBC ( 1.3% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van EMBC naar verwachting over 3 jaar hoog zal zijn
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
